Pharmaceuticals, Biotechnology and Life Sciences
Astellas Pharma will have an expedited review process for gilteritinib, as the U.S. Food and Drug Administration (FDA) granted fast track…
Diplomat Pharmacy will dispense newly approved Eli Lilly’s Verzenio(abemaciclib), a twice-daily oral therapy for advanced breast cancer. Verzenio is indicated…
Eli Lilly’s Phase 3 JUNIPER study evaluating Verzenio (abemaciclib), a cyclin-dependent kinase (CDK)4 and CDK6 inhibitor, as monotherapy in KRAS-mutated, advanced…
Pertinax Pharma on Tuesday revealed launching of its Pertinax technology, which provides controlled and sustained delivery of chlorhexidine (CHX). The…
Mundipharma EDO GmbH (EDO) has begun a US Phase 1/2 clinical study for tinostamustine (EDO-S101) in patients with advanced solid…
ThromboGenics’s preclinical data on its THR-317 have been published in Experimental Eye Research, the company said on Monday.
AstraZeneca Monday said that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the…
The 2017 Nobel Prize in chemistry has been awarded to three scientists who developed a technique called cryo-electron microscopy (Cryo-EM), which simplifies…
Swedish Orphan Biovitrum AB (publ) (Sobi) has appointed Norbert Oppitz as Senior Vice President for the newly established business area Specialty Care.
TiGenix NV has achieved positive results from its ADMIRE-CD Phase III clinical trial of Cx601 for the treatment of complex perianal…